Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Deloitte
AstraZeneca
McKinsey
Cantor Fitzgerald
Chubb
Moodys
McKesson
Farmers Insurance
Johnson and Johnson

Generated: August 17, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 202286

« Back to Dashboard
NDA 202286 describes TRANEXAMIC ACID, which is a drug marketed by Micro Labs, Emcure Pharms Ltd, Mylan, Akorn, Aurobindo Pharma Ltd, Acic Fine Chems, Gland Pharma Ltd, Amneal Pharms Co, North Creek Pharms, Amerigen Pharms Ltd, Mylan Institutional, X-gen Pharms Inc, Luitpold, Apotex Inc, Actavis Labs Fl Inc, and Fresenius Kabi Usa, and is included in seventeen NDAs. It is available from eighteen suppliers. Additional details are available on the TRANEXAMIC ACID profile page.

The generic ingredient in TRANEXAMIC ACID is tranexamic acid. There are seven drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the tranexamic acid profile page.

Summary for NDA: 202286

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Blood Products/Modifiers/ Volume Expanders
Formulation / Manufacturing:see details

Pharmacology for NDA: 202286

Physiological EffectDecreased Fibrinolysis

Suppliers and Packaging for NDA: 202286

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TRANEXAMIC ACID
tranexamic acid
TABLET;ORAL 202286 ANDA Golden State Medical Supply, Inc. 60429-084 60429-084-30 30 TABLET in 1 BOTTLE (60429-084-30)
TRANEXAMIC ACID
tranexamic acid
TABLET;ORAL 202286 ANDA Apotex Corp. 60505-3638 60505-3638-1 100 TABLET in 1 BOTTLE (60505-3638-1)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength650MG
Approval Date:Jan 27, 2014TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
Merck
Daiichi Sankyo
Deloitte
McKesson
Federal Trade Commission
Colorcon
Cantor Fitzgerald
Novartis
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot